HPDL and spastic paraplegia 83, autosomal recessive: Finally, the proven capacity to reproduce HPDL mutant cortical tissue and to achieve the same maturation milestones as described for wild-type cells provides a reliable in vitro model for future research aimed at understanding the molecular and cellular mechanisms underlying the etiopathogenesis of SPG83, thereby paving the way for the potential development of targeted therapies.